Challenges and Opportunities of Metal Chelation Therapy in Trace Metals Overload-Induced Alzheimer’s Disease
Authors:
- 27 January 2023
- journal article
- review article
- Published by Springer Nature in Neurotoxicity Research
- Vol. 41 (3) , 270-287
Abstract
Essential trace metals like zinc (Zn), iron (Fe), and copper (Cu) play an important physiological role in the metabolomics and healthy functioning of body organs, including the brain. However, abnormal accumulation of trace metals in the brain and dyshomeostasis in the different regions of the brain have emerged as contributing factors in neuronal degeneration, Aβ aggregation, and Tau formation. The link between these essential trace metal ions and the risk of AD has been widely studied, although the conclusions have been ambiguous. Despite the absence of evidence for any clinical benefit, therapeutic chelation is still hypothesized to be a therapeutic option for AD. Furthermore, the parameters like bioavailability, ability to cross the BBB, and chelation specificity must be taken into consideration while selecting a suitable chelation therapy. The data in this review summarizes that the primary intervention in AD is brain metal homeostasis along with brain metal scavenging. This review evaluates the impact of different trace metals (Cu, Zn, Fe) on normal brain functioning and their association with neurodegeneration in AD. Also, it investigates the therapeutic potential of metal chelators in the management of AD. An extensive literature search was carried out on the “Web of Science, PubMed, Science Direct, and Google Scholar” to investigate the effect of trace elements in neurological impairment and the role of metal chelators in AD. In addition, the current review highlights the advantages and limitations of chelation therapies and the difficulties involved in developing selective metal chelation therapy in AD patients.Keywords
Funding Information
- Anusandhan National Research Foundation (CRG/2020/003316)
This publication has 181 references indexed in Scilit:
- Copper Chelator Induced Efficient Episodic Memory Recovery in a Non-Transgenic Alzheimer’s Mouse ModelPLOS ONE, 2012
- Effect of Zinc Binding on β-Amyloid Structure and Dynamics: Implications for Aβ AggregationBiophysical Journal, 2011
- Iron Promotes the Toxicity of Amyloid β Peptide by Impeding Its Ordered AggregationJournal of Biological Chemistry, 2011
- Dietary zinc supplementation of 3xTg-AD mice increases BDNF levels and prevents cognitive deficits as well as mitochondrial dysfunctionCell Death & Disease, 2010
- A Prochelator Activated by β-Secretase Inhibits Aβ Aggregation and Suppresses Copper-Induced Reactive Oxygen Species FormationJournal of the American Chemical Society, 2010
- Alterations of Zinc Transporter Proteins ZnT‐1, ZnT‐4 and ZnT‐6 in Preclinical Alzheimer's Disease BrainBrain Pathology, 2010
- Increasing Cu bioavailability inhibits Aβ oligomers and tau phosphorylationProceedings of the National Academy of Sciences, 2009
- Copper transport to the brain by the blood-brain barrier and blood-CSF barrierBrain Research, 2009
- Intake of copper has no effect on cognition in patients with mild Alzheimer’s disease: a pilot phase 2 clinical trialJournal of Neural Transmission, 2008
- Neurodegenerative diseases and oxidative stressNature Reviews Drug Discovery, 2004